Results 241 to 250 of about 298,427 (334)

Molecular Mechanisms of Emerging Antidepressant Strategies: From Ketamine to Neuromodulation. [PDF]

open access: yesInt J Mol Sci
Kowalczyk M   +5 more
europepmc   +1 more source

New antidepressants

open access: yesComprehensive Psychiatry, 1983
openaire   +2 more sources

A New Phenotype–Genotype Correlation for FIG4 and Parkinson's Disease

open access: yes
Movement Disorders Clinical Practice, EarlyView.
Iro Boura   +4 more
wiley   +1 more source

Association of Glucagon‐Like Peptide‐1 Receptor Agonists With Cancer Risk in Older Adults With Type 2 Diabetes

open access: yesObesity, EarlyView.
ABSTRACT Objective The real‐world evidence on the association between glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) and cancer risk remains limited and mixed. Methods In 2013–2020 national Medicare claims data, we included cancer‐naïve patients with type 2 diabetes (T2D). We identified those who initiated GLP‐1 RA, sodium‐glucose cotransporter 2
Ying Lu   +13 more
wiley   +1 more source

PMH31 A GPRD-BASED COMPARISON OF SECOND-LINE ANTIDEPRESSANT THERAPY WITH ESCITALOPRAM AND VENLAFAXINE

open access: bronze, 2008
AG Wade   +4 more
openalex   +1 more source

Psychiatric Safety of Tirzepatide in People With Obesity and No Known Major Psychopathology: A Post Hoc Analysis of SURMOUNT

open access: yesObesity, EarlyView.
ABSTRACT Objective This post hoc analysis assessed psychiatric changes with tirzepatide in adults with obesity, without known major psychopathology, from SURMOUNT‐1, SURMOUNT‐2, and SURMOUNT‐3. Methods In participants (N = 4056) treated with tirzepatide (5/10/15 mg or maximum tolerated dose 10/15 mg) versus placebo, depressive symptoms and suicidal ...
Thomas A. Wadden   +6 more
wiley   +1 more source

The risk of an acute attack of angle-closure glaucoma during the treatment with modern antidepressant drugs

open access: green, 2018
T. V. Romanova   +7 more
openalex   +1 more source

Home - About - Disclaimer - Privacy